ArticleBMC cancer2025
Primary analysis of malignant neoplasm trends and demographics in hospitalized patients in Kashi prefecture from 2016 to 2023.
Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
objectiveTo analyze the ranking, composition, trend changes, and distribution by gender and ethnicity of malignant neoplasms in hospitalized patients in the Kashi prefecture from 2016 to 2023. This analysis aims to provide a reference for the prevention and treatment of malignant neoplasms, screening programs, public education, medical resource allocation, and the development of hospital developments in the Kashi prefecture.
methodsWe collected the front-page data of medical records for malignant neoplasm patients from 2016 to 2023 at four comprehensive hospitals in the Kashi prefecture, and analyze the ranking, composition, and trend changes of diseases among hospitalized patients with malignant neoplasms.
resultsA total of 8,386 patients with malignant neoplasms were hospitalized. The number of hospitalizations for patients with malignant neoplasms showed an increasing trend from 2016 to 2023. The incidence of malignant neoplasms began to rise rapidly after the age of 40 and peaks at 70 years old. Among the top 10 types of malignant neoplasms, there were 5,918 hospitalizations, accounting for 70.5% of cases. Of these, gastrointestinal malignancies constituted 43.6%. The most common malignant neoplasm in males was malignant neoplasm of stomach, while in females, it was malignant neoplasm of cervix uteri. Differences in the ranking of malignant neoplasm were observed among different ethnic groups, with malignant neoplasm of gastrointestinal accounting for as high as 44.8% among minority ethnicities.
conclusionThe most common malignant neoplasms requiring hospitalization in this area include those of the stomach, esophagus, cervix uteri, breast, and colorectum. Health promotion and early screening strategies should be tailored based on the observed hospitalization patterns. Additionally, medical resources should be allocated efficiently, and support for relevant disciplines should be strengthened to address these prevalent conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.